BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grillo TG, Quaglio AEV, Beraldo RF, Lima TB, Baima JP, Di Stasi LC, Sassaki LY. MicroRNA expression in inflammatory bowel disease-associated colorectal cancer. World J Gastrointest Oncol 2021; 13(9): 995-1016 [PMID: 34616508 DOI: 10.4251/wjgo.v13.i9.995] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Boros É, Hegedűs Z, Kellermayer Z, Balogh P, Nagy I. Global alteration of colonic microRNAome landscape associated with inflammatory bowel disease. Front Immunol 2022;13:991346. [DOI: 10.3389/fimmu.2022.991346] [Reference Citation Analysis]
2 Meng W, Li Z, Zhang Y, Yang A, Wang Y, Zhou Y, Wu W, Qiu Y, Li L. ZhenQi FuZheng formula inhibits the growth of colorectal tumors by modulating intestinal microflora-mediated immune function. Aging (Albany NY) 2022;14:4769-85. [PMID: 35680568 DOI: 10.18632/aging.204111] [Reference Citation Analysis]
3 Wu J, Wu Y, Feng W, Chen Q, Wang D, Liu M, Yu H, Zhang Y, Wang T. Role of Microbial Metabolites of Histidine in the Development of Colitis. Mol Nutr Food Res 2022;:e2101175. [PMID: 35585003 DOI: 10.1002/mnfr.202101175] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Abaach M, Morilla I. Learning models for colorectal cancer signature reconstruction and classification in patients with chronic inflammatory bowel disease. Artif Intell Cancer 2022; 3(2): 27-41 [DOI: 10.35713/aic.v3.i2.27] [Reference Citation Analysis]